
News from drugtopics.com
Top drugtopics.com News

FDA · EmporiaMany treatments for hemophilia A and B are administered via intravenous infusions, so the approval offers a subcutaneous injection for the treatment for patients 12 years and older.See the Story
FDA Approves Concizumab as Daily Prophylaxis for Hemophilia A and B
66% Center coverage: 24 sources